Nicotinic modulation of gene expression in SH-SY5Y neuroblastoma cells

Brain Research

Volumn 1116, Issue 1, 2006, Pages 39-49

  Dunckley, Travis ^a   Lukas, Ronald J ^a  

^a Barrow Clinic   (United States)

Author keywords

Gene expression; Microarray; nAChR; Neuroblastoma cells; Nicotine; SH SY5Y cells; Upregulation

Indexed keywords

CELL PROTEIN; CONTACTIN; MYOZENIN 2; NICOTINE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; RECEPTOR SUBTYPE; TUBOCURARINE CHLORIDE; UBIQUITIN CONJUGATING ENZYME; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CELL LINE; CONTROLLED STUDY; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENE INTERACTION; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; NEUROBLASTOMA CELL; NEUROMODULATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR AFFINITY; RECEPTOR BINDING; RECEPTOR INTRINSIC ACTIVITY; RECEPTOR UPREGULATION;

BRAIN NEOPLASMS; CELL LINE, TUMOR; DNA, COMPLEMENTARY; DNA, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IN SITU HYBRIDIZATION; NEUROBLASTOMA; NICOTINE; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RADIOLIGAND ASSAY; RECEPTORS, NICOTINIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION;

EID: 33749239615     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.07.111     Document Type: Article

References (36)

1. Allam M.F., Del Castillo A.S., and Navajas R.F. Parkinson's disease, smoking and family history: meta-analysis. Eur. J. Neurol. 10 (2003) 59-62
2. Belluardo N., Olsson P.A., Mudo' G., Summer W.H., Amato G., and Fuxe K. Transcription factor gene expression profiling after acute intermittent nicotine treatment in the rat cerebral cortex. Neuroscience 133 (2005) 787-796
3. Bencherif M., Fowler K., Lukas R.J., and Lippiello P.M. Mechanisms of upregulation of neuronal nicotinic acetylcholine receptors in clonal cell lines and primary cultures of fetal rat brain. J. Pharmacol. Exp. Ther. 275 (1995) 987-994
4. Brunzell D.H., Russell D.S., and Picciotto M.R. In vivo nicotine treatment regulates mesocorticolimbic CREB and ERK signaling in C57Bl/6J mice. J. Neurochem. 84 (2003) 1431-1441
5. Checkoway H., Powers K., Smith-Weller T., Franklin G.M., Longstreth Jr. W.T., and Swanson P.D. Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake. Am. J. Epidemiol. 155 (2002) 732-738
6. Dajas-Bailador F., and Wonnacott S. Nicotinic acetylcholine receptors and the regulation of neuronal signaling. Trends Pharmacol. Sci. 25 (2004) 317-324
7. Dajas-Bailador F.A., Soliakov L., and Wonnacott S. Nicotine activates the extracellular signal-regulated kinase 1/2 via the alpha7 nicotinic acetylcholine receptor and protein kinase A in SH-SY5Y cells and hippocampal neurones. J. Neurochem. 80 (2002) 520-530
8. DiAntonio A., Haghighi A.P., Portman S.L., Lee J.D., Amaranto A.M., and Goodman C.S. Ubiquitination-dependent mechanisms regulate synaptic growth and function. Nature 412 (2001) 449-452
9. Donnely-Roberts D.L., and Brioni J.D. Preclinical evidence on the neuroprotective effects of nicotinic ligands. In: Arneric S.P., and Brioni J.D. (Eds). Neuronal Nicotinic Receptors: Pharmacology and Therapeutic Opportunities (1999), Wiley-Liss, Inc., New York 337-348
10. Dunckley T., and Lukas R.J. Nicotine modulates the expression of a diverse set of genes in the neuronal SH-SY5Y cell line. J. Biol. Chem. 278 (2003) 15633-15640
11. 2+ permeability of nicotinic acetylcholine receptors. Cell Calcium 35 (2004) 1-8
12. Gentry C.L., and Lukas R.J. Regulation of nicotinic acetylcholine receptor numbers and function by chronic nicotine exposure. Curr. Drug Targets-CNS Neurol. Disord. 1 (2002) 359-385
13. Huang Z., de la Fuente-Fernandez R., and Stoessl A.J. Etiology of Parkinson's disease. Can. J. Neurol. Sci. 30 (2003) S10-S18
14. Jensen A.A., Frolund B., Liljefors T., and Krogsgaard-Larsen P. Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations. J. Med. Chem. 48 (2005) 4705-4745
15. Ji D., Lape R., and Dani J.A. Timing and location of nicotinic activity enhances or depresses hippocampal synaptic plasticity. Neuron 31 (2001) 31-141
16. Kane J.K., Konu O., Ma J.Z., and Li M.D. Nicotine coregulates multiple pathways involved in protein modification/degradation in the rat brain. Mol. Brain Res. 132 (2004) 181-191
17. + channels and increases their functional expression. J. Neurosci. 21 (2001) 7517-7525
18. Ke L., Eisenhour C.E., Bencherif M., and Lukas R.J. Effects of chronic nicotine treatment on expression and function of diverse nicotinic receptor subtypes. I. Dose- and time dependent effects of nicotine treatment. J. Pharmacol. Exp. Ther. 286 (1998) 825-840
19. Keller S.H., Lindstrom J., and Taylor P. Inhibition of glucose trimming with castanospermine reduces calnexin association and promotes proteasome degradation of the alpha-subunit of the nicotinic acetylcholine receptor. J. Biol. Chem. 273 (1998) 17064-17072
20. Konu O., Kane J.K., Barrett T., Vawter M.P., Chang R., Ma J.Z., Donovan D.M., Sharp B., Becker K.G., and Li M.D. Region-specific transcriptional response to chronic nicotine in rat brain. Brain Res. 909 (2001) 194-203
21. Konu O., Xu X., Ma J.Z., Kane J., Wang J., Shi S.J., and Li M.D. Application of a customized pathway-focused microarray for gene expression profiling of cellular homeostasis upon exposure to nicotine in PC12 cells. Mol. Brain Res. 121 (2004) 102-113
22. Levin E.D., and Simon B.B. Nicotinic acetylcholine involvement in cognitive function in animals. Psychopharmacology 138 (1998) 217-230
23. Li S.P., Park M.S., Bahk J.Y., and Kim M.O. Chronic nicotine and smoking exposure decreases GABA(B1) receptor expression in the rat hippocampus. Neurosci. Lett. 334 (2003) 135-139
24. Li M.D., Kane J.K., Wang J., and Ma J.Z. Time-dependent changes in transcriptional profiles within five rat brain regions in response to nicotine treatment. Mol. Brain Res. 132 (2004) 168-180
25. Lioudyno M., Hiel H., Kong J.H., Katz E., Waldman E., Parameshwaran-Iyer S., Glowatzki E., and Fuchs PA. A "synaptoplasmic cistern" mediates rapid inhibition of cochlear hair cells. J. Neurosci. 24 (2004) 11160-11164
26. Lukas R.J., and Bencherif M. Recent developments in nicotinic acetylcholine receptor biology. In: Arias H. (Ed). Biological and Biophysical Aspects of Ligand-Gated Ion Channel Receptor Superfamilies (2006), Research Signpost, Trivandrum 27-59
27. Lukas R.J., Norman S.A., and Lucero L. Characterization of nicotinic acetylcholine receptors expressed by cells of the SH-SY5Y human neuroblastoma clonal line. Mol. Cell. Neurosci. 4 (1993) 1-12
28. Mexal S., Frank M., Berger R., Adams C.E., Ross R.G., Freedman R., and Leonard S. Differential modulation of gene expression in the NMDA postsynaptic density of schizophrenic and control smokers. Mol. Brain Res. 139 (2005) 317-332
29. Nakayama H., Numakawa T., and Ikeuchi T. Nicotine-induced phosphorylation of Akt through epidermal growth factor receptor and Src in PC12h cells. J. Neurochem. 83 (2002) 1372-1379
30. Papke R.L., Sanberg P.R., and Shytle R.D. Analysis of mecamylamine stereoisomers on human nicotinic receptor subtypes. J. Pharmacol. Exp. Ther. 297 (2001) 646-656
31. Peng X., Gerzanich V., Anand R., Wang F., and Lindstrom J. Chronic nicotine treatment upregulates alpha3 and alpha7 acetylcholine receptor subtypes expressed by the human neuroblastoma cell line SH-SY5Y. Mol. Pharmacol. 51 (1997) 776-784
32. Sharma G., and Vijayaraghavan S. Nicotinic receptor signaling in nonexcitable cells. J. Neurobiol. 53 (2002) 524-534
33. Shoop R.D., Esquenazi E., Yamada N., Ellisman M.H., and Berg D.K. Ultrastructure of a somatic spine mat for nicotinic signaling in neurons. J. Neurosci. 22 (2002) 748-756
34. Shytle R.D., Silver A.A., Lukas R.J., Newman M.B., Sheehan D.V., and Sanberg P.R. Nicotinic acetylcholine receptors as targets for antidepressants. Mol. Psychiatry 7 (2002) 525-535
35. Stachowiak M.K., Goc A., Hong J.-S., Kaplan B., and Stachowiak E.K. Neural and hormonal regulation of the tyrosine hydroxylase gene in adrenal medullary cells: participation of c-fos and AP1 factors. Mol. Cell. Neurosci. 1 (1988) 202-213
36. Sun B., Sterling C.R., and Tank A.W. Chronic nicotine treatment leads to sustained stimulation of tyrosine hydroxylase gene transcription rate in rat adrenal medulla. J. Pharmacol. Exp. Ther. 304 (2003) 575-588